Protalix at Morgan Stanley conference: rare-disease growth in focus

Investing.com•Wed, Sep 16, 2026, 05:40 PM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Investing.com](https://www.investing.com/news/transcripts/protalix-at-morgan-stanley-conference-raredisease-growth-in-focus-93CH-4904229)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Investing.com ↗

#finance #protalix #morgan #stanley #conference #rare #disease #growth #focus

More Headlines

FinanceCNBC• 4m ago

10-year Treasury yield falls as traders bet Fed rate increase can tamp down inflation

The Federal Reserve is widely expected to hike interest rates on Wednesday.

FinanceCNBC• 5m ago

Fed approves interest rate hike, signals one more to come this year

The Federal Reserve on Wednesday approved its first interest rate hike in more than three years and indicated another to come.

FinanceSeeking Alpha• 6m ago

WidePoint: Investors Are Confused About A Contract Ceiling - Sell

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 8m ago

Sandisk: The Market Is Still Underestimating Its New Earnings Power

Developing story — details emerging. Check the source link for the latest updates.

FinanceThe Hill• 8m ago

Fed hikes interest rates by quarter-point

The Federal Reserve raised interest rates Wednesday for the first time in several years in the face of stubborn inflation. The central bank’s Federal Open Market Committee (FOMC), under Fed Chair Kevin Warsh, voted unanimously to increase the federal funds rate to a range of 3. 75 percent to 4 p...

FinanceSeeking Alpha• 8m ago

Ares Management Corporation (ARES) Presents at Barclays 24th Annual Global Financial Services Conference Transcript

Developing story — details emerging. Check the source link for the latest updates.